Pictet Asset Management (Switzerland)’s CONMED CNMD Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$461K	Sell	3,393 -385	-10%	-$47K	﹤0.01%	1283
2023 Q1	$392K	Buy	3,778 +504	+15%	+$48.7K	﹤0.01%	1361
2022 Q4	$290K	Buy	+3,274	New	+$272K	﹤0.01%	1511
2022 Q2	–	Sell	-2,066	Closed	-$307K	–	1600
2022 Q1	$307K	Buy	2,066 +218	+12%	+$30.4K	﹤0.01%	1350
2021 Q4	$262K	Sell	1,848 -352	-16%	-$49.9K	﹤0.01%	1463
2021 Q3	$288K	Buy	+2,200	New	+$288K	﹤0.01%	1431

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s CNMD Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its CONMED (CNMD) stake by 10% in Q2 2023, selling an estimated $47K and leaving 3,393 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #1283.

Pictet Asset Management (Switzerland) first reported a position in CNMD in Q3 2021 and has held it in 6 quarters since. 263 funds tracked by Wall St. Rank hold CNMD as of Q2 2023.

Pictet Asset Management (Switzerland) held 3,393 shares of CONMED worth $461K as of Q2 2023.
Pictet Asset Management (Switzerland) sold 385 CONMED shares in Q2 2023, an estimated $47K.
CONMED made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1283 holding.
Pictet Asset Management (Switzerland) first reported a position in CONMED in Q3 2021 and has held it in 6 quarters since.
263 funds tracked by Wall St. Rank held CONMED as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.